225 related articles for article (PubMed ID: 26574625)
1. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
[TBL] [Abstract][Full Text] [Related]
3. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
[TBL] [Abstract][Full Text] [Related]
4. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.
Santos FM; Telles RW; Lanna CC; Teixeira AL; Miranda AS; Rocha NP; Ribeiro AL
Lupus; 2017 Jan; 26(1):10-16. PubMed ID: 27365371
[TBL] [Abstract][Full Text] [Related]
5. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
6. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
8. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
9. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
[TBL] [Abstract][Full Text] [Related]
10. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
Denollet J; Vrints CJ; Conraads VM
Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia.
Noto C; Gadelha A; Belangero SI; Spindola LM; Rocha NP; de Miranda AS; Teixeira AL; Cardoso Smith MA; de Jesus Mari J; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Apr; 47(4):467-71. PubMed ID: 23360651
[TBL] [Abstract][Full Text] [Related]
13. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
[TBL] [Abstract][Full Text] [Related]
14. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
15. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia.
Minuz P; Fava C; Hao S; Pedraza P; Amen G; Meneguzzi A; Vattemi G; Marini M; Zanconato G; Ferreri NR
J Matern Fetal Neonatal Med; 2015 May; 28(8):869-75. PubMed ID: 25034210
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.
Svenungsson E; Fei GZ; Jensen-Urstad K; de Faire U; Hamsten A; Frostegard J
Lupus; 2003; 12(6):454-61. PubMed ID: 12873047
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of infliximab in active SLE: a pilot study.
Uppal SS; Hayat SJ; Raghupathy R
Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
[TBL] [Abstract][Full Text] [Related]
20. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease].
Olszanecka-Glinianowicz M; Waluszek-Kończakowska I; Zahorska-Markiewicz B; Janowska J
Endokrynol Pol; 2005; 56(2):174-8. PubMed ID: 16335686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]